Happy Holidays from all of us at ICON. We’re sending every best wish for health, happiness and success in 2026.
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
How real world evidence is impacting rare disease drug development
Will Maier, VP of Rare Diseases, shares how a more patient-focused approach to trials is leading to alternatives for randomisation.
-
What Biotech and Pharma need to consider about decentralised trials
Discuss key considerations when implementing decentralised clinical trials, in addition to the success factors that lead to more patient-centric trials and increased patient recruitment, engagement and retention.
-
Patient centricity in insulin injection: Using technology to improve self-administration
David T. Novotny, General Manager & Global Head of ICON’s Medical Device and Diagnostic Research business unit, considers the current and future developments in injection technology.
-
-
Navigating the patient maze – pharma’s evolving challenge
Chris O'Toole considers the challenges that pharma companies may face when adopting a more patient-centric approach.
-
Pharma’s coming home
Seth Nelson, Senior Director of Patient Recruitment and Clinical Research Services, provides expert commentary on patient centricity during the pandemic.
-
Trailblazing women stress importance of diversity in pharma
Nuala Murphy, President of Clinical Research Services at ICON, discusses how increasing diversity is a key area of focus for ICON, both in terms of patient diversity and diversity in the organisation.
-
The pursuit of patient diversity in clinical trials
Nuala Murphy, President of Clinical Research Services, provides expert commentary on the importance of patient diversity in clinical trials.
-
Ensuring patient safety and cardiovascular clinical trial integrity during a global pandemic
Jack Martin and Deirdre Albertson provide insights on ensuring patient safety and cardiovascular clinical trial integrity during a global pandemic.
-
True patient-focused research through decentralised and hybrid trials
ICON experts offer insights on the key approaches and technologies that are driving patient engagement forward.
